表關遺傳學在近些年來蓬勃發展，且 DNA 甲基化是其重要的研究方向。而究竟什麼是 DNA 甲基化？

在了解 DNA 甲基化前，我們必須了解何謂基因位點 ( locus )。基因位點實際上是指基因上的特定位置，它為我們提供了關於這個基因的位置信息，就像地圖上的坐標一樣，告訴我們基因所在的確切位置。而這些位點影響了基因的特徵和生理功能，控制基因是否表現。

DNA甲基化是指在基因位點中加上甲基基團（一種化學組分）的過程，通常會控制著基因的活性，進而在不改變DNA序列本身，影響著基因的功能。

簡單來說，DNA甲基化就像在一條水管上安裝閥門一樣。想像這條水管代表著基因位點，而水流代表基因的活性。當你在水管上安裝閥門時，你可以通過控制閥門的開啟和關閉，調節水流的速度和量。同樣地，DNA甲基化就是在DNA分子上添加一種 '閥門'，這種閥門就是甲基基團。這個 '閥門' 可以控制基因的活性，當它打開時，基因表達，當它關閉時，基因不表達。所以，DNA甲基化的過程就像是調節水流的閥門，控制基因的運作，進而影響細胞的功能和特徵。對於生物學和表觀遺傳學非常重要，它讓我們知道 DNA 甲基化如何在不改變 DNA 序列下調節基因的活性。

然而，在 DNA 實驗中，我們需要一個額外的參考點，這就是內部控制基因，通常以泛用於各實驗之管家基因作為使用，像是常用之管家基因有 GAPDH、ACTB。內部控制基因是一組已由許多實驗證實穩定的基因，所以它們時常在廣泛的實驗中充當參考點。就像實驗室中使用標準參考物質來校正儀器一樣，內部控制基因確保我們的實驗結果穩定而可靠。內部控制基因就是充當實驗中的參考點，協助我們校正和比較不同樣本的表現量，以確保我們的結果正確且可靠。

儘管內部控制基因在 DNA 甲基化研究中非常重要，但我們也必須謹慎地選擇它們，因為在不同疾病或實驗條件下，特定的內部控制基因可能不適用。所以任意選用管家基因做為參考基準，最後的研究結果可能會導致實驗結果有嚴重錯誤的推論。綜上所論，且適用於 DNA 甲基化的內控基因稀少，現今許多實驗依舊使用傳統舊有的管家基因作為客觀參考基準，所以我們決定探索以及驗證在 DNA 甲基化實驗中表現穩定的基因，為未來在 DNA 甲基化研究時提供一個可靠並且準確的內部控制參考基準基因。


###### 基因位點
基因上的每個座標，且人的身體裡有著千萬個位點

###### 甲基化
以不改變 DNA 序列的方式，調控著基因的表現

###### 內部控制基因
實驗上的客觀參考基準，以確保結果可靠

# Citation

| No. | Paper Name                                                                                                                                                                                                                                  | Journal                                                | Date        |
| --- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------ | ----------- |
| **1**   | What is precision medicine?                                                                                                                                                                                                                 | Eur Respir J                                           | 2017 Oct 19 |
| **2**   | Artificial Intelligence in Cancer Research and Precision Medicine                                                                                                                                                                           | Cancer Discov                                          | 2021 Apr    |
| **3**   | Machine learning for precision medicine                                                                                                                                                                                                     | Genome                                                 | 2021 Apr    |
| **4**   | Clinical trial design in the era of precision medicine                                                                                                                                                                                      | Clinical trial design in the era of precision medicine | 2022 Aug 31 |
| **5**   | Analysis of DNA methylation in cancer: location revisited                                                                                                                                                                                   | Nat Rev Clin Oncol                                     | 2018 Jul    |
| **6**   | The DNA methylation landscape in cancer. Essays Biochem                                                                                                                                                                                     | Essays Biochem                                         | 2019 Dec 20 |
| **7**   | DNA methylation based biomarkers: practical considerations and applications                                                                                                                                                                 | Biochimie                                              | 2012 Nov    |
| **8**   | Blood-based DNA methylation signatures in cancer: A systematic review                                                                                                                                                                       | Biochim Biophys Acta Mol Basis Dis                     | 2023 Jan 1  |
| **9**   | MethMarkerDB: a comprehensive cancer DNA methylation biomarker database                                                                                                                                                                     | Nucleic Acids Res                                      | 2023 Oct 27 |
| **10**  | The DNA methyltransferase family: a versatile toolkit for epigenetic regulation                                                                                                                                                             | Nat Rev Genet                                          | 2018 Feb    |
| **11**  | DNA methylation and its basic function                                                                                                                                                                                                      | Neuropsychopharmacology                                | 2013 Jan    |
| **12**  | Identification of DNA-Methylated CpG Islands Associated With Gene Silencing in the Adult Body Tissues of the Ogye Chicken Using RNA-Seq and Reduced Representation Bisulfite Sequencing                                                     | Front Genet                                            | 2019 Apr 16 |
| **13**  | What are housekeeping genes?                                                                                                                                                                                                                | PloS Comput Biol                                       | 2022 Jul 13 |
| **14**  | How many human genes can be defined as housekeeping with current expression data?                                                                                                                                                           | BMC Genomics                                           | 2008 Apr 16 |
| **15**  | On the nature of human housekeeping genes                                                                                                                                                                                                   | Trends Genet                                           | 2008 Oct    |
| **16**  | Identification of human housekeeping genes and tissue-selective genes by microarray meta-analysis                                                                                                                                           | PloS One                                               | 2011 Jul 27 |
| **17**  | A compendium of gene expression in normal human tissues                                                                                                                                                                                     | Physiol Genomics                                       | 2001 Dec 21 |
| **18**  | Identification of novel universal housekeeping genes by statistical analysis of microarray data                                                                                                                                             | J Biochem Mol Biol                                     | 2007 Mar 31 |
| **19**  | Definition, conservation and epigenetics of housekeeping and tissue-enriched genes                                                                                                                                                          | BMC Genomics                                           | 2009 Jun 17 |
| **20**  | Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes                                                                                                                                     | Physiological Genomics                                 | 2000 Apr 27 |
| **21**  | Human housekeeping genes, revisited                                                                                                                                                                                                         | Trends Genet                                           | 2013 Oct    |
| **22**  | Selection of an inadequate housekeeping gene leads to misinterpretation of target gene expression in zinc deficiency and zinc supplementation models                                                                                        | J Trace Elem Med Biol                                  | 2019 Dec    |
| **23**  | CARM1 Methylates GAPDH to Regulate Glucose Metabolism and Is Suppressed in Liver Cancer                                                                                                                                                     | Cell Rep                                               | 2018 Sep 18 |
| **24**  | Housekeeping genes as internal standards in cancer research                                                                                                                                                                                 | Mol Diagn                                              | 2004        |
| **25**  | A pan-cancer analysis of the prognostic and immunological role of β-actin (ACTB) in human cancers                                                                                                                                           | Bioengineered                                          | 2021 Dec    |
| **26**  | Whole blood ACTB, B2M and GAPDH expression reflects activity of inflammatory bowel disease, advancement of colorectal cancer, and correlates with circulating inflammatory and angiogenic factors: Relevance for real-time quantitative PCR | Adv Clin Exp Med                                       | 2020 May    |
| **27**  | Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314                                                                                  | Eur Urol Oncol                                         | 2023 Oct    |
| **28**  | Global DNA hypermethylation pattern and unique gene expression signature in liver cancer from patients with Indigenous American ancestry                                                                                                    | Oncotarget                                             | 2021 Mar 2  |
| **29**  | Epigenome-Wide Study Identifies Epigenetic Outliers in Normal Mucosa of Patients with Colorectal Cancer                                                                                                                                     | Cancer Prev Res (Phila)                                | 2022 Nov 1  |
| **30**  | Two Distinct Tumorigenic Processes in Endometrial Endometrioid Adenocarcinoma                                                                                                                                                               | Am J Pathol                                            | 2020 Jan    |
| **31**  | A comprehensive survey of clustering algorithms: State-of-the-art machine learning applications, taxonomy, challenges, and future research prospects. Engineering Applications of Artificial Intelligence                                   | Engineering Applications of Artificial Intelligence    | 2022 Apr    |
| **32**  | ChAMP: updated methylation analysis pipeline for Illumina BeadChips                                                                                                                                                                         | Bioinformatics                                         | 2017 Dec 15 |
| **33**  | A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data                                                                                                               | Bioinformatics                                         | 2013 Jan 15 |
| **34**  | A robust internal control for high-precision DNA methylation analyses by droplet digital PCR                                                                                                                                                | Clin Epigenetics                                       | 2018 Feb 21 |
| **35**  | Comparing different supervised machine learning algorithms for disease prediction                                                                                                                                                           | BMC Med Inform Decis Mak                               | 2019 Dec 21 |
| **36**  | The incidence and prevalence of cardiovascular diseases in gout: a systematic review and meta-analysis                                                                                                                                      | Rheumatol Int                                          | 2021 Jul    |
| **37**  | Comorbidities and factors influencing frequent gout attacks in patients with gout: a cross-sectional study                                                                                                                                  | Clin Rheumatol                                         | 2021 Jul    |
| **38**  | Understanding the Impact of Uterine Fibroids on Human Endometrium Function                                                                                                                                                                  | Front Cell Dev Biol                                    | 2021 May 25 |
| **39**  | Gastrointestinal manifestations in systemic autoimmune diseases                                                                                                                                                                             | Maedica (Bucur)                                        | 2011 Jan    |
| **40**  | Association of asthma and bipolar disorder: a nationwide population-based study in Taiwan                                                                                                                                                   | Journal of Affective Disorders                         | 2014 Oct    |
| **41**  | Stroke risk and outcomes in epilepsy patients: Two retrospective cohort studies based on National Health Insurance in Taiwan                                                                                                                | Atherosclerosis                                        | 2019 Jan    |
| **42**  | Validation of housekeeping genes for the normalization of RT-qPCR expression studies in oral squamous cell carcinoma cell line treated by 5 kinds of chemotherapy drugs                                                                     | Cell Mol Biol (Noisy-le-grand)                         | 2016 Nov 30 |
| **43**  | Validation of reference genes for the normalization of RT-qPCR expression studies in human tongue carcinoma cell lines and tissue                                                                                                           | Oncol Lett                                             | 2017 May    |
| **44**  | Reference genes in real-time PCR                                                                                                                                                                                                            | Journal of Applied Genetics                            | 2013 Nov    |
| **45**  | A pan-cancer analysis of the prognostic and immunological role of β-actin (ACTB) in human cancers                                                                                                                                           | Bioengineered                                          | 2021 Dec    |
| **46**  | ACTB in cancer                                                                                                                                                                                                                              | Clin Chim Acta                                         | 2013 Feb 18 |
| **47**  | GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues                                                                                                                                              | Physiological Genomics                                 | 2005 May 11 |
| **48**  | Novel insight into the role of GAPDH playing in tumor                                                                                                                                                                                       | Clin Transl Oncol                                      | 2013 Mar    |
| **49**  | Pleiotropic effects of moonlighting glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in cancer progression, invasiveness, and metastases                                                                                                    | Cancer Metastasis Rev                                  | 2018 Dec    |
| **50**  | Prevalence and Clinical Characteristics of Hearing Loss Caused by MYH14 Variants                                                                                                                                                            | Genes (Basel)                                          | 2021 Oct 15 |
| **51**  | Genetic association of MYH genes with hereditary hearing loss in Korea                                                                                                                                                                      | Gene                                                   | 2016 Oct 10 |
| **52**  | Real-time PCR in clinical microbiology: applications for routine laboratory testing                                                                                                                                                         | Clin Microbiol Rev                                     | 2006 Jan    |

# 為什麼論文不會過

#### MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING
- 2023 IF : 2.6
- Rank by JIF
	- COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS
		- 80/169
		- Q2
	- ENGINEERING, BIOMEDICAL
		- 71/122
		- Q3
	- MATHEMATICAL & COMPUTATIONAL BIOLOGY
		- 20/65
		- Q2
	- MEDICAL INFORMATICS
		- 26/44
		- Q3

#### JOURNAL OF BIOMEDICAL INFORMATICS
- 2023 IF : 4.0
- CiteScore : 8.9
- Rank by JIF
	- COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS
		- 45/169
		- Q2
	- MEDICAL INFORMATICS
		- 14/44
		- Q2
- 時間可能要考慮
- 提交的費用要 USD 3010
- 出版社很大，ACADEMIC PRESS INC ELSEVIER SCIENCE
- https://www.sciencedirect.com/journal/journal-of-biomedical-informatics

> [!info] 重點領域和關注主題
> JBI發表有關各種信息學主題的論文。但是,在這些主題中,論文必須以對醫學領域知識的深刻理解和利用為基礎,並應考慮對臨床護理或應用進行務實的翻譯。

> [!info] 數據聲明
> 如果您的數據無法訪問或不適合發布,您將有機會在提交過程中指出原因,例如聲明研究數據是機密的。該聲明將與您發表的有關ScienceDirect的文章一起出現。https://www.elsevier.com/researcher/author/tools-and-resources/research-data/data-statement



#### CANCER BIOLOGY & THERPAPY
- JIF : 4.4
- Rank by JIF
	- ONCOLOGY
		- 86/322
		- Q2

#### Human Cell
- JIF : 3.4
- Rank by JIF 
	- CELL BIOLOGY
		- 114/205
		- Q3
- 感覺他分數低，也很雜

#### HUMAN MOLECULAR GENETICS
- JIF : 3.1
- Rank by JIF
	- BIOCHEMISTRY & MOLECULAR BIOLOGY
		- 168/313
		- Q3
	- GENETICS & HEREDITY
		- 73/191
		- Q2
- 這個跟遺傳學有關

#### Journal of the Chinese Medical Association
- JIF : 1.9
- Rank by JIF
	- MEDICINE, GENERAL & INTERNAL
		- 105/329
		- Q2


# 乳癌講稿

大家好，我們今天要演講的是論文是，Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer。

以上是我們這次講述的outline，我們會先從介紹、方法到最後結論與討論。

那我由先從 introduction 開始做簡報的開頭，

作者在開頭說明了為什麼要選擇乳癌作為研究目標，在 2018 年時，有研究指出了女性罹患癌症的群體當中，共有將近1/4的人罹患乳癌，約莫 200 萬的人數，並在因癌症死亡的女性裡，乳癌的佔比也有了15%之多。

而除了作者所提及的2018年的資料，我們有另外找尋其他年份的資料，我們找到同一團隊在 2020 年的資料，在研究女性癌症的佔比時，乳癌的佔比依然為第一名，佔比將近罹患人數的 1/4，而死亡的人數也是居高第一。這樣可了解在女性癌症中，乳癌在主要因素當中佔了一個極重大的腳色，若能夠透過研究的方法提出治療或是預測的方法，必能有效的對於乳癌有所幫助。

找到了研究的目標後，作者在探討文獻時，發現在兩個蛋白質對於乳癌是治療的重要角色。在數篇文獻都提及了 HR 以及 HER2 參與了乳癌的致癌過程。
所以作者要以兩者作為分析目標，以後續分析。

了解分析目標後，作者要探討針對 NGS 作為分析工具，對於樣本患者提取 DNA 數據，作為分析樣本，同時也探討 NGS 對於台灣患者的適用性。

本次的研究除了使用了 CMMC 所提供的116個樣本外，研究結果的驗證也是透過了 MSKCC 作為對象，使用這個驗證集的資料，比對台灣乳癌的患者與西方患者是否有所不同，西方患者的治療方式是否適合台灣的乳癌患者。

那麼我會先從 Method 開始介紹本次研究的流程

本篇論文的研究分成了 4 個步驟
從 
Study population、
Sample preparation、
Targeted Panel Sequencing、
Bioinformatics Studies，

那麼我們先從 Study Population 開始，我們會提及實驗用的樣本介紹

對於樣本的了解，我們統整了總共有 116 位患者，並且樣本都來自於 CMMC，並且中心所提供的臨床資訊有像是TNM 的分期以及醫護報告等，讓後續的分析有所依據，透過這些臨床資訊也可更加瞭解每筆患者樣本的數據。

然後我們會介紹在進行 NGS 定序分析前，作者對於樣本的前處理，透過各種的方法將樣本去除雜質以及讓樣本的數據能夠更好的在後續分析做使用。

之前有所提及 HR 以及 HER2 會作為本研究的分析目標，則分析需要知道患者的這兩個目標的狀態才可分析。所以作者透過 IHC 將兩個目標分析狀態。

那我們可以先了解什麼 IHC，IHC 是透過，細胞對應的酶的反應程度，透過專家分析狀態，這是IHC的過程。
- 使用primary antibody 確認所要標記的蛋白質
- 再使用 Secondary Antibody 結合 Primary antibody，加強訊號
- 使用酶催化反應
- 最後使標記上色，讓觀察者能夠觀察

那麼透過了 IHC 的分析，HR 即能透過專家判定每位患者的樣本狀態

則 HER2 被專家分析為四個狀態，

所以作者將0,1作為Negative，而3作為Positive，而2的話因為較難判定的原因

所以他們透過 ISH 的方法，將HER2被判定為2+的樣本區分狀態，

那我們在簡單介紹什麼是ISH，簡單解釋，ISH 透過對應的基因序列雜交過後，透過探針的檢測拷貝量判定樣本的狀態，而流程如圖
- Put IHC 2+ tissue in ISH test.
- Use probe complementary HER2 gene to hybridized.
- The copy number of HER2 is determined by the probe result.
- Based on the copy number, the sample status will be determined to be positive or negative.

而區分樣本的各種狀態後，作者將樣本透過QIAamp DNA FFPE tissue kit的方式提取樣本中的 DNA 的數據

This tool main purpose is to get high purity DNA saample. First, to remove paraffin from the FFPE samples, break down the cell structure and release the DNA, then remove cross-link the DNA with the proteins, and then wash the impurities and combine the DNA samples in a silicone mold to obtain high purity DNA samples, which are suitable for the authors' analysis of the NGS.

得到高純度的DNA樣本過後，作者也使用兩個工具偵測每個樣本的 DNA 濃度，確保後續的分析能有所應用，而透過這兩個工具提供精確的質量評估

而這兩者不同的在於，
- Fragment Analyzer 是一種基於毛細管電泳的分析儀，用於檢測 DNA 或 RNA 的片段大小分佈和完整性。
- Qubit 是一種螢光定量儀器，專門用於準確測量 DNA、RNA 或蛋白質的濃度，特別是在低濃度範圍內

得到了品質控制過後的樣本後，作者將樣本透過定序儀檢測，以後續分析

放到Ion Torrent 平台定序儀中，而得到的結果透過 Ion Torrent Suite 讀取 raw reads 將數據 map 到 hg19 上。
再來透過 Torrent Variant Caller 確認DNA序列中的問題點，像是 SNV, Indel, CNVs
並用Clinvar, COSMIC 以及 Genome aggregation database 為所分析的目標基因註解以及解釋
也使用ONCOCNV對於基因突變的拷貝數異常進行正規化。
並且透過 TMB 量化了基因突變的密度，等等會解釋。

那我們稍微解釋剛剛在定序儀完後所分析突變的重點
他所提及的SNV、Indel、CNVs

- SNV是Single Nucleotide Variants，就是在序列當中單一位點的突變，像是從ATCG變成了GTCG，這樣可能會影響後續 RNA 轉錄的結果。
- 而Indel則指的是 Insertions and Deletions，像是ATCG變成了ATCGG等，則課堂中也有提及這個結果，同樣會造成RNA轉錄的結果，影響後續翻譯成蛋白質時會有所不同。
- 而最後 CNVs 是計算因為突變所造成的拷貝數擴增還是減少，則能了解到因為突變所造成影響的基因。

TMB 全名叫做 Tumor Mutational Burden，表示在百萬個DNA鹼基對中有多少個突變數量，當作為測量突變密度的方法，而用途在於可以作為revalidaion biomarker的數據，並且能夠為腫瘤分級的依據

得到了研究的數據，則能夠根據統計數據的分析，透過數據分析能夠更加證明作者所得到的結果。
- 在數據的 Descriptive Statistics 中，統整了臨床資料，像是年齡分部等。
- 而 Mann-Whitney U test 用於比較年齡在差距中的比較
- Pearson's Chi-squared test 用於比較各種分類變數上統計意義的比較
- Disease-free survival 作為比較Time from diagnosis to metastasis or local recurrence of the tumor


Hello everyone, the paper we are presenting today is **"Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer."**

This is the outline of our presentation. We will start from the introduction, move through the methods, and conclude with the results and discussion.

I will begin with the introduction.

The authors start by explaining why they chose breast cancer as the research focus. In 2018, a study pointed out that among women diagnosed with cancer, nearly **one-quarter were diagnosed with breast cancer**, with approximately 2 million cases. Among cancer-related deaths in women, breast cancer also accounted for as much as **15%**.

In addition to the 2018 data provided by the authors, we also looked for data from other years. We found data from the same research team in 2020, showing that breast cancer still ranked **first** in the proportion of female cancer cases, accounting for **nearly one-quarter** of cases. Breast cancer also remained the leading cause of cancer-related deaths in women. This highlights the critical role breast cancer plays in women's health. If research methods can propose effective treatments or predictive approaches, they could significantly benefit breast cancer patients.

After identifying the research objective, the authors reviewed the literature and found that two proteins play important roles in breast cancer treatment. Several studies have highlighted **HR** and **HER2** as key participants in the carcinogenesis of breast cancer. Therefore, the authors chose these two proteins as their targets for subsequent analysis.

With the targets identified, the authors decided to explore **NGS (Next-Generation Sequencing)** as a tool to extract DNA data from patient samples and analyze their profiles. The authors also aimed to evaluate the applicability of NGS for Taiwanese breast cancer patients.

The study not only used 116 samples provided by CMMC but also validated the research results using data from MSKCC. By comparing these validation data, the authors assessed whether breast cancer characteristics in Taiwanese patients differ from those of Western patients and whether Western treatment approaches are suitable for Taiwanese breast cancer patients.

Now, let's move to the **Methods**, where we explain the research process.

This study consists of four steps:

1. Study population,
2. Sample preparation,
3. Targeted panel sequencing, and
4. Bioinformatics studies.

Let’s begin with the **Study Population** to introduce the samples used in the study.

The study involved 116 patients, with samples obtained from CMMC. The clinical information provided by the center included data such as **TNM staging** and medical reports, which served as the foundation for subsequent analyses. These clinical details allowed the researchers to better understand the data for each patient sample.

Next, we introduce the **preprocessing of samples** before NGS analysis. The authors employed various methods to remove impurities from the samples, ensuring they were suitable for downstream analysis.

Since the study targets **HR** and **HER2**, it was necessary to determine the status of these two proteins for each patient sample. The authors used **IHC (Immunohistochemistry)** to analyze these protein statuses.

Let’s briefly discuss what IHC is. IHC is a process that analyzes cellular enzyme activity. Through this method, experts evaluate protein statuses. The steps of IHC include:

1. Using **primary antibodies** to identify the target proteins.
2. Applying **secondary antibodies** to bind to the primary antibodies and amplify the signal.
3. Catalyzing a reaction using enzymes.
4. Finally, staining the target, allowing visual observation.

Using IHC, experts assessed the status of **HR** in patient samples.

For **HER2**, experts categorized samples into four statuses:

- Scores of **0 and 1+** were classified as **negative**.
- A score of **3+** was classified as **positive**.
- A score of **2+**, which is more challenging to determine, required further assessment using **ISH**.

Let’s briefly explain **ISH (In Situ Hybridization)**. ISH determines the HER2 status for 2+ samples by hybridizing complementary gene sequences and assessing copy numbers. The steps include:

1. Placing IHC 2+ tissue into ISH testing.
2. Using probes complementary to HER2 genes to hybridize.
3. Determining HER2 copy numbers based on probe results.
4. Classifying the samples as positive or negative based on copy numbers.

After identifying the statuses of the samples, the authors used the **QIAamp DNA FFPE Tissue Kit** to extract DNA data from the samples.

This kit aims to obtain high-purity DNA samples. The process involves removing paraffin from FFPE samples, breaking down cell structures to release DNA, removing DNA-protein cross-links, washing out impurities, and combining DNA into a silica mold to obtain high-purity DNA suitable for NGS analysis.

After obtaining high-purity DNA, the authors used two tools to measure DNA concentrations to ensure the samples were suitable for downstream applications. These tools provided precise quality assessments:

- **Fragment Analyzer** detects DNA or RNA fragment size distribution and integrity using capillary electrophoresis.
- **Qubit** is a fluorometric quantitation tool that accurately measures DNA, RNA, or protein concentration, especially in low-concentration samples.

After quality control, the samples were sequenced using the **Ion Torrent platform**. The raw reads were mapped to **hg19** using the Ion Torrent Suite. The **Torrent Variant Caller** was used to identify variants such as **SNVs, Indels, and CNVs**.

Annotated variants were interpreted using databases such as **ClinVar, COSMIC, and Genome Aggregation Database**. Copy number abnormalities were normalized using **ONCOCNV**. Additionally, **TMB** was used to quantify mutational density.

Let’s briefly explain these mutations:

- **SNVs (Single Nucleotide Variants):** Single nucleotide changes (e.g., ATCG → GTCG) that may affect RNA transcription.
- **Indels (Insertions and Deletions):** Additions or deletions of nucleotides (e.g., ATCG → ATCGG) that could alter RNA transcription and protein translation.
- **CNVs (Copy Number Variations):** Amplifications or deletions of gene copies, providing insight into genetic impact caused by mutations.

**TMB (Tumor Mutational Burden):** Measures the number of mutations per million DNA bases, serving as a biomarker for tumor classification and mutation density analysis.

Finally, the research results were statistically analyzed:

- **Descriptive statistics** summarized clinical data like age distribution.
- **Mann-Whitney U test** compared age differences between groups.
- **Pearson’s Chi-squared test** assessed statistical differences among categorical variables.
- **Disease-Free Survival (DFS)** compared the time from diagnosis to tumor metastasis or local recurrence.


## OOAD_midterm
- u2_1
	- Controller
		- BorrowController
		- 為系統事件的接收者，將使用者的意圖導入系統
		- 代表著**使用者介面邏輯**，不處理邏輯判斷，符合"誰處理輸入系統事件"
	- Information Expert
		- BorrowMapper
		- Mapper 擁有操作資料庫的專業知識，處理查詢的人
		- 而他擁有資料，符合"擁有資訊的人負責該責任"，所以查詢邏輯給予Mapper
	- Low Coupling
		- BorrowController $\rightarrow$ BorrowService $\rightarrow$ BorrowMapper
		- 每層都有明確的職責，只有必要依賴
		- 調用其他層方法
	- High Cohesion
		- BorrowService
		- 只專注於邏輯判斷，無混入UI及資料層職責
- u2_2
	- Controller
		- 僅接受外部的請求，派給 Service 任務，遵守了"Controller不做業務邏輯"的原則
	- High Cohesion & Low Coupling
		- BorrowService負責邏輯，聚焦在歸還、更新判斷，實踐了高內聚
		- BookInfoService以及ReservationRecordService僅做了自己的事情，低耦合
		- 並且不跨層呼叫 Mapper，則可達到低耦合的概念
	- Information Expert
		- BookInfoMapper、BorrowMapper、ReservationRecordMapper，為操作資料的對象，因為他們知道如何處理資料並且擁有資料
	- Creator
		- BorrowService
		- 對於所有的角色而言，BorrowService 是對於創造借閱紀錄最好的角色，所以我們認為符合Creator
- u2_3
	- Controller
		- 只負責外部事件，處理流程，不參予邏輯判斷
		- 遵守"單一職責原則"
	- Information Expert
		- ReservationRecordController
		- 掌握資料負責資料存取
	- High Cohesion
		- ReservationRecordService
		- 在其中做了所有邏輯判斷，符合高內聚
	- Low Coupling
		- 每層依層呼叫，無跳層或是跨模組
		- 要變動修改或是資料來源，只需要修改各Mapper以及Service，降低影響
- u2_4
	- Controller
		- ReservationRecordController
		- 負責UI分派的業務給 Service
	- Information Expert
		- Mapper最了解資料予查詢邏輯的角色，擔任操作資料的專家
	- High Cohesion
		- ReservationRecordService
		- 專注處理預約邏輯相關的職責
	- Low Coupling
		- 各層只呼叫相鄰層，避免了跨層耦合，提高模組獨立性